Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform
- 1 September 2013
- journal article
- review article
- Published by Elsevier in Clinical Immunology
- Vol. 149 (3) , 297-306
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8 + T Cells in Type 1 DiabetesScience Translational Medicine, 2013
- Can we vaccinate against Type 1 diabetes?F1000 Biology Reports, 2012
- Humoral Autoimmunity in Type 1 Diabetes: Prediction, Significance, and Detection of Distinct Disease SubtypesCold Spring Harbor Perspectives in Medicine, 2012
- GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes MellitusNew England Journal of Medicine, 2012
- Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patientsJournal of Experimental Medicine, 2012
- Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosisAnnals of Neurology, 2008
- Induction of Antigen-Specific Tolerance in Multiple Sclerosis After Immunization With DNA Encoding Myelin Basic Protein in a Randomized, Placebo-Controlled Phase 1/2 TrialArchives of Neurology, 2007
- Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing TregsJournal of Clinical Investigation, 2006
- An Immunomodulatory GpG Oligonucleotide for the Treatment of Autoimmunity via the Innate and Adaptive Immune SystemsThe Journal of Immunology, 2003
- Plasmid Vaccination with Insulin B Chain Prevents Autoimmune Diabetes in Nonobese Diabetic MiceThe Journal of Immunology, 2001